Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 19191632.
- Also identified by DOI 10.1086/597010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Multidrug-resistant tuberculosis (TB) strains resistant to the fluoroquinolones and streptomycin but susceptible to second-line injection treatment would not be defined as extensively drug-resistant TB. In a cohort of 174 patients with multidrug-resistant TB, we demonstrated that 12 patients with multidrug-resistant TB strains resistant to the fluoroquinolones and streptomycin had significantly better initial and long-term outcomes, compared with 10 patients with extensively drug-resistant TB.
Medical subject headings
- Antitubercular Agents
- Extensively Drug-Resistant Tuberculosis
- Fluoroquinolones
- Streptomycin
- Tuberculosis, Multidrug-Resistant